The LL-37 Peptide Acne Face Mask is a microbiome-safe clarifying treatment engineered to target active breakouts, congestion, and blemish-prone skin without disrupting your skin's natural bacterial balance. This professional-grade mask delivers antimicrobial peptide LL-37 alongside salicylic acid and niacinamide through an occlusive microfiber matrix—calming inflammation, balancing oil production, and refining pores in just 20 minutes.
LL-37 (Cathelicidin) is a naturally occurring antimicrobial peptide that your immune system produces to fight bacterial infections. Unlike harsh antibiotics or benzoyl peroxide that kill both good and bad bacteria, LL-37 selectively targets acne-causing bacteria (C. acnes) while preserving beneficial skin flora. This makes it ideal for sensitive-acne skin that reacts poorly to traditional acne treatments.
LL-37 also possesses powerful anti-inflammatory properties, reducing the redness and swelling associated with cystic acne and inflammatory breakouts. It works by modulating immune responses and inhibiting pro-inflammatory cytokines, calming active blemishes without the irritation or dryness caused by conventional spot treatments.
Salicylic Acid (BHA) penetrates deep into pores to dissolve sebum plugs and dead skin cells, preventing new breakouts from forming. Niacinamide regulates oil production, reduces pore appearance, and fades post-acne marks by inhibiting melanin transfer. Together, these ingredients create a comprehensive acne-fighting protocol that addresses congestion, active inflammation, and post-breakout scarring.
This mask is ideal for acne-prone skin, hormonal breakouts, congested pores, or anyone seeking a gentler alternative to harsh acne medications. Use 2-3 times weekly for prevention, or apply to specific breakout zones as a targeted treatment during active flare-ups.
ProGlow Tip:
Apply this mask after gentle exfoliation to maximize pore penetration. For stubborn cystic acne, leave the mask on for 30-40 minutes or use as an overnight spot treatment on problem areas.